Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/3e68a4ea-4aa6-49fd-8305-c0624813f7bc/

MOH

Molina Healthcare Inc
Chart
197.55 USD
Latest Week 2026-07-24
Snapshot 2026-07-26 · 0.4w · Fresh
0.1
OS Score
11.0%
Value
16.0%
Quality
73.0%
Momentum
5/9
F-Score
0.133
QV
Strategy Eligibility
1 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
4.8%
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
11.0%ile
P/S
0.2×
P/B
2.5×
E/P
0.0219
FCF Yield
0.050
EBITDA/EV
0.040
SH Yield
0.048
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
73.00000000
/100 — 1=cheapest
VC2 (Trending Value)
68.00000000
/100
VC3 (Buyback)
70.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
16.0%ile
ROE
-0.002
ROA
0.000
Net Margin
0.000
Op Margin
0.005
GPA
0.962
D/E
2.84
Current
1.68
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.026
Stability
1.207
lower=better
Accruals
-0.023
lower=better
5yr Consist
No
Highly leveraged with D/E of 2.84 — returns are being amplified by debt.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
73.0%ile
6M Return
-2.1%
12M Return
19.7%
12-1 Mom
39.2%
Risk-Adj
0.69
Vol 252d
56.5%
Vol 60d
131.6%
↑ Expanding
Max DD 12M
-34.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 39% is very strong — a clear uptrend. Near-term vol (132%) is expanding vs long-term (57%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.1
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
3.6%
Sector Quality %ile
3.2%
P/B z-score
-0.19
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
INVA Innoviva Inc 97.0% 94.0% 94.0% 67.0%
Factor Interactions
Volatility Expanding
60-day vol (132%) significantly exceeds 252-day (57%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
53.8% avg (6 factors)
Quality
D
34.7% avg (8 factors)
Momentum
C
54.5% avg (4 factors)
Risk
F
22.5% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.100—8
Value %ile0.110—8
Quality %ile0.160—8
Momentum %ile0.730—1
F-Score5.000—0
Confidence0.939—8
Volatility0.565—8
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Earnings Yield (E/P)
0.0219
Price / Sales
0.23
Price / Book
2.47
Price / Cash Flow
28.25
FCF Yield
5.0%
EBITDA / EV
4.0%
Sales Yield (1/P·S)
4.7976
Shareholder Yield
Div + net buyback / mktcap
4.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-0.2%
Return on Assets
-0.0%
Net Margin
-0.0%
Operating Margin
0.5%
Gross Profit / Assets
Novy-Marx GPA
96.2%
Debt / Equity
2.84
Current Ratio
1.68
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.023
MomentumPrice trend strength over different horizons
6M Return
-2.1%
12M Return
19.7%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
39.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.69
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
2.6%
Earnings Stability (CV)
Lower = more stable
1.207
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
4.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
73
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
68
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
70
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity